Skip to content

DE PAENHOEVE

Active Private limited company (pre-2019)founded 1998active for 28 yearsWeverstraat 48, 3940 Hechtel-EkselKBO/BCE: BE 0462.916.068

Lifetime

9 annual accounts with figures on one time axis
peak of €177,485 in 2017
€10,368▲ 22.6%
lowest -€32,096 in 2018
-€17,165▼ €396
peak of €130,279 in 2017
-€17,732▼ €17,165
€267,533▼ 0.1%
Board2 names since 1998
2 directors and 1 other
Documentsfilings and deeds
20-07-202611 days before the deadline
2025micro format
Gross margin from €8,456 to €10,368Loss of €17,165Equity from -€568 to -€17,732

Key points

from the 2025 annual accounts

Equity

-€17,732
202020212022202320242025

Debts exceed assets in financial year 2025.

Losses

-€163,951 in eight years
-32,0962018-18,1282019-18,5242020-17,6772021-20,7132022-22,8812023-16,7682024-17,1652025

Every financial year from 2018 to 2025 closed with a loss. 2018 was the heaviest.

Debts

€267,533 96% of the balance sheet
Financial debts 35%Suppliers 1%Other 64%

Of this, €174,163 falls due within a year.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,796 companies had the same profile as DE PAENHOEVE has now. Each dot stands for 7 companies, two years later.

90.3%
were still trading
6.1%
stopped another way
2.1%
went bankrupt
  • Micro
  • 20 years or older
  • negative equity
  • a small loss

Another 1.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,796 companies, not a prediction for DE PAENHOEVE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, since 11-03-1998
Director, since 27-07-2017
  • 310 sharesdeed of 30-10-2017
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0462916068
Publication in the Belgian Official Gazette Gazette deed
Demerger: VERSUS-OMEGA splits off to VERSUS INVEST Capital increase of €15,000 to €35,000 · The capital rose from €20,000 to €35,000, with 310 new shares · holds 310 shares · General meeting of 29-09-2017 · Gazette deed
Company renamed from Verbiest Consulting to DE PAENHOEVE Capital increase of €17,856.32 to €18,600 · The capital rose from €743.68 to €18,600 · (statutory manager) and (statutory manager) appointed · General meeting of 27-09-2017 · Gazette deed
All 16 events

Official details

Source: KBO
Status
Active since 19-03-1998Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 2110001and 2 others3 activities on the establishment unitFrom the articles, 5 activities
Establishment unit
2.085.942.1412300 Turnhout, since 19-03-1998
Financial year end
31 December
Peppol
Reachable since 17-12-2025
Company details

Annual accounts 2025

≈ €77,000estimated
€277,823▼ 6.7%
Filing
Filed on 20-07-2026, 11 days before the end of the filing period
Financials

Insights on DE PAENHOEVE

DE PAENHOEVE files the micro format. That format states no turnover. The gross margin fell from €177,485 in 2017 to €10,368 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DE PAENHOEVE

What is the company number of DE PAENHOEVE?
The company number of DE PAENHOEVE is 0462.916.068. The VAT number is the same number with BE in front: BE 0462.916.068.
Where is DE PAENHOEVE based?
The registered office is at Weverstraat 48, 3940 Hechtel-Eksel.Company details
What does DE PAENHOEVE do?
According to the KBO register, the main activity of the establishment unit is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 2110001). The KBO lists 2 more.
What is the legal form of DE PAENHOEVE?
DE PAENHOEVE is a private limited company (pre-2019) (BVBA).
When was DE PAENHOEVE founded?
DE PAENHOEVE was founded on 19-03-1998.
Is DE PAENHOEVE still active?
Yes, DE PAENHOEVE is an active enterprise in the KBO register.
What is the turnover of DE PAENHOEVE?
The turnover in financial year 2025 is about €77,000. This figure is estimated from the gross margin of €10,368 and 7,102 comparable companies of the same size. It probably lies between €35,000 and €180,000. It is a rough estimate.Financials
Is DE PAENHOEVE profitable?
In financial year 2025, DE PAENHOEVE made a loss of €17,165.
Where can I find the annual accounts of DE PAENHOEVE?
DE PAENHOEVE filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DE PAENHOEVE due?
DE PAENHOEVE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.